SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000882796-05-000028
Filing Date
2005-06-01
Accepted
2005-06-01 12:00:58
Documents
1
Period of Report
2005-05-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 3681
  Complete submission text file 0000882796-05-000028.txt   5479
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 205-444-4600
Nugent Jonathan M (Reporting) CIK: 0001327027 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23186 | Film No.: 05869656